2023242
Last Update Posted: 2019-12-10
Recruiting has ended
All Genders accepted | 45 Years-84 Years |
152 Estimated Participants | No Expanded Access |
Interventional Study | Does not accept healthy volunteers |
Comparing Effectiveness of the Hydrus Microstent (TM) to Two iStents to Lower IOP in Phakic Eyes
This clinical trial compares two implantable devices intended to lower the pressure inside the eye of glaucoma patients.
This is a prospective, multicenter, single-masked, randomized clinical trial comparing the Hydrus Microstent to two iStent implants for the reduction of intraocular pressure in phakic patients with a positive diagnosis of primary open angle glaucoma, pseudoexfoliative glaucoma, or pigmentary dispersion glaucoma. Post-operative follow-up visits will be conducted at regular intervals.
Eligibility
Relevant conditions:
Primary Open Angle Glaucoma
Pseudoexfoliative Glaucoma
Pigmentary Glaucoma
If you aren't sure if you meet the criteria above speak to your healthcare professional. Criteria may be updated but not reflected here, do not hesitate to contact the trial if you think are close to fitting criteria.
locations
Data sourced from ClinicalTrials.gov